RDC ILAC ARASTIRMA VE GELISTIRME S.A.

Company Type:

RDC ILAC ARASTIRMA VE GELISTIRME S.A. is primarily a pharmaceutical research and development company. Its full legal name, RDC İlaç Araştırma ve Geliştirme Sanayi ve Ticaret A.Ş., includes "Sanayi" (Industry/Manufacturing), indicating involvement in industrial production and development processes. Therefore, it functions as a pharmaceutical R&D and development company with industrial production capabilities, rather than solely a trader. It operates as a developer and industrial producer of pharmaceutical products.

Company Introduction:

RDC İlaç Araştırma ve Geliştirme S.A. (RDC Pharmaceutical Research and Development Inc.) is a Turkish company dedicated to innovation within the pharmaceutical sector. The company specializes in the research and development of novel pharmaceutical products and technologies. Its core activities include conducting preclinical and clinical studies, developing advanced formulations, and managing intellectual property. RDC İlaç operates with state-of-the-art laboratories for comprehensive research, development, and quality control, with the objective of bringing innovative and high-quality pharmaceutical solutions to the market.

RDC ILAC ARASTIRMA VE GELISTIRME S.A. primarily operates as a contract research and development company in the pharmaceutical industry. They do not typically manufacture or sell finished pharmaceutical products under their own brand directly to consumers or pharmacies.

Instead, they provide specialized services and expertise to other pharmaceutical companies. Their outputs are in the form of research, development, and analytical services rather than commercial products. These services include:

Formulation development for various dosage forms

Analytical method development and validation

Bioequivalence and bioavailability studies

Stability studies

Pre-formulation studies

Quality control and assurance services for drug development

Therefore, they do not have a product portfolio of drugs that they produce or sell in the market. Their focus is on supporting other pharmaceutical companies in the development and registration of their own drug products.